Browsing: Women in Bio

Almost two-thirds of Americans living with Alzheimer’s disease are women. Women in their 60’s are more than twice as likely…

Yaso Therapeutics gel technology takes aim at sperm before they can reach an egg, creating a non-hormonal contraceptive that prevents…

Women have historically been denied the right to have a stake in the development of medical therapies targeting their health,…

A rare genetic respiratory disease affecting the tiny structures in the lungs that filter air is the target of promising…

After a bullish 2021, characterized by a flow of M&A deals and IPOs, this year company valuations were in correction,…

Smart Immune is a clinical-stage biotechnology startup headquartered in France, developing a thymus-empowered T-cell therapy platform called ProTcell Platform. The…

Advanced neuroimaging techniques that can detect disease-linked proteins in the brain could be the key to quickly and accurately diagnosing…

Chronic kidney disease (CKD) affects more than 1 in 7 U.S. adults and approximately 2 in 1,000 Americans live with…

One company’s approach to breaking barriers within the TME to overcome recalcitrant cancers. Earlier this month, a preview of patient-derived…

Cala Heath, Inc. is a bioelectronic medicine company that develops non-invasive neuromodulation therapies for chronic diseases through wearable devices. Their…

Prostate cancer is the second most common form of cancer affecting men in the United States – 1 in 8 men will…